Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Cancer ; 104(3): 469-79, 2011 Feb 01.
Article in English | MEDLINE | ID: mdl-21179030

ABSTRACT

BACKGROUND: Metastasis is associated with poor prognosis for melanoma. The formation of metastases is a multi-step process, in which cancer cells can subsequently acquire the potential to intravasate into the blood or lymph vessels, disseminate through the circulation, extravasate through the endothelium and invade the connective tissue. There is increasing evidence that chemokines have a pivotal role in the dissemination and establishment of melanoma metastasis. METHODS: We isolated melanoma cells from melanoma metastasis and performed different migration assays and transendothelial resistance measurements of endothelial monolayers co-cultured with melanoma cells, in order to monitor barrier function and diapedesis and confirmed these results by confocal microscopy. RESULTS: We observed that tumour endothelial cells (ECs) secrete high levels of CXCL9 in all, and CXCL10 in most melanoma metastases. Migration studies revealed that low concentrations of these chemokines induce chemotaxis, whereas high concentrations induce spontaneous migration of melanoma cells (chemokinesis/chemorepulsion) and the disruption of the endothelial barrier, resulting in an accelerated transendothelial migration (TEM). Addition of anti-CXCL9 or anti-CXCR3 antibodies to the co-cultures delayed the TEM of melanoma cells. CONCLUSION: Our data represent novel mechanisms by which tumour cells in melanoma metastases might use the chemokine-expressing endothelium to leave the tumour and eventually to form additional metastases at distinct sites.


Subject(s)
Chemokine CXCL9/metabolism , Melanoma/metabolism , Receptors, CXCR3/biosynthesis , Skin Neoplasms/metabolism , Transendothelial and Transepithelial Migration/immunology , Chemotaxis , Humans
2.
Assay Drug Dev Technol ; 4(6): 709-19, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17199509

ABSTRACT

The yeast two-hybrid (Y2H) method is capable of delivering vast amounts of interacting positive yeast colonies from a single library screen, particularly if a multifunctional protein is used as bait. However, the selection of definitive colonies for further molecular analysis is limited by both technical practicality and high costs. Here we demonstrate a cost-effective and simple method for the rapid selection and ranking of those Y2H-positive interaction clones that are suitable for further analysis. We performed a Y2H screen for the identification of human transforming growth factor beta2- interacting proteins in a human skin keratinocyte library. The identified clones were ranked by the amount of beta-galactosidase enzyme produced, as well as by the interaction strength of the positive colonies. The combination of high-throughput microplate fluorescence readers and specific fluorescence assays can be utilized for relative quantitation of protein-protein interaction strength of Y2H-positive colonies in crude yeast-cell lysates. We demonstrate here that the high sensitivity of the fluorescence approach can bypass cumbersome conventional methods of cell lysis used in beta-galactosidase assays, and still deliver accurate values for analysis of protein interaction data. Finally, we also achieved a better understanding of general aspects of beta-galactosidase measurements in the Y2H system, such as protein normalization, the influence of yeast culture incubation time on optimal beta-galactosidase detection, and the linearity of beta-galactosidase detection in crude cell lysates.


Subject(s)
Protein Interaction Mapping/methods , Two-Hybrid System Techniques , Yeasts/genetics , beta-Galactosidase/metabolism , Cost-Benefit Analysis , False Positive Reactions , Fluorescence , Gene Library , Humans , Keratinocytes/enzymology , Organic Chemicals , Sensitivity and Specificity
3.
Curr Genet ; 34(6): 419-29, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9933353

ABSTRACT

The yeast gene, GRC5 (growth control), is a member of the highly conserved QM gene family, the human member of which has been associated with the suppression of Wilms' tumor. GRC5 encodes ribosomal protein L10, which is thought to play a regulatory role in the translational control of gene expression. A revertant screen identified four spontaneous revertants of the mutant grc5-1ts allele. Genetic and phenotypic analysis showed that these represent one gene, NMD3, and that the interaction of NMD3 and GRC5 is gene-specific. NMD3 was previously identified as a component of the nonsense-mediated mRNA decay pathway. The point mutations within NMD3 reported here may define a domain important for the functional interaction of Grc5p and Nmd3p.


Subject(s)
Gene Expression Regulation , Genes, Fungal , Protein Biosynthesis , Saccharomyces cerevisiae/genetics , Alleles , Amino Acid Sequence , Animals , Base Sequence , DNA Primers/genetics , Humans , Molecular Sequence Data , Mutation , Phenotype , Ribosomal Protein L10 , Ribosomal Proteins/genetics , Sequence Homology, Amino Acid , Wilms Tumor/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...